US 12,729,381 B2
Methods and compositions for inactivating interleukin-2-inducible t-cell kinase (ITK)
Mobin Karimi, Manlius, NY (US); and Alaji Bah, Baldwinsville, NY (US)
Assigned to The Research Foundation for the State University of New York, Albany, NY (US)
Appl. No. 17/918,230
Filed by The Research Foundation for the State University of New York, Albany, NY (US)
PCT Filed Apr. 9, 2021, PCT No. PCT/US2021/026724
§ 371(c)(1), (2) Date Oct. 11, 2022,
PCT Pub. No. WO2021/207706, PCT Pub. Date Oct. 14, 2021.
Claims priority of provisional application 63/007,593, filed on Apr. 9, 2020.
Prior Publication US 2023/0141417 A1, May 11, 2023
Int. Cl. C12N 15/113 (2010.01)
CPC C12N 15/1137 (2013.01) [C12N 2310/14 (2013.01)] 4 Claims
OG exemplary drawing
 
1. A synthetic nucleic acid encoding a peptide inhibitor having a sequence identity to SEQ ID NO: 2, wherein the peptide inhibitor comprises a phosphorylated tyrosine.